Y-27632 Dihydrochloride Hydrate
Pfizer recently detailed a number of C-suite shakeups coming in the wake of its incoming CEO Albert Bourla.
Perhaps most relevant to Mobi readers is the appointment of the company’s first chief digital and technology officer, Lidia Fonseca. Currently the CIO and SVP at Quest Diagnostics, Fonseca has also held tenure at the Laboratory Corporation of America, Synarc Incorporated and Philips Healthcare.
Dr. Kirsten Lund-Jurgensen, EVP and president of Pfizer Global Supply, as well as Laurie Olson, EVP of strategy and commercial operations, will both be retiring with the new year.
Virtual care company Doctor On Demand announced today that it has taken on a slew of new executive hires, including Facebook and Flipboard executive Jeff McCombs as chief financial officer, American Telemedicine Association alumni Latoya Thomas as director of policy and government affairs and the company’s own Dr. Prentiss Taylor as VP of medical affairs.
“We look forward to this next part of our journey and our expanded leadership team,” Hill Ferguson, CEO of Doctor On Demand, said in a statement. “With these new members on board, we can continue to make the necessary steps to grow, innovate, and shape the future of healthcare.”
John Graham, the CEO and chairman of Integrity Applications, which makes the non-invasive blood sugar measurement device GlucoTrack, has stepped down from his posts for “personal reasons,” according to a release from the company. David Podwalski, Integrity’s chief commercial officer, has been appointed CEO, president, and director during the interim, while Graham will be on hand to “ensure a smooth transition with ongoing projects and relationships.
Podwalski has spent more than 20 years of leadership experience in the industry, and previously served at Ernst & Young, Aventis Pharmaceuticals, and Lantus.
“I have worked side by side with John Graham for the better part of the last 20 years and together we have launched life-changing diabetic solutions,” Podwalski said in a statement. “We are enormously grateful for John’s contribution to the company for the last year and half and wish him well. I am excited about my new role and for the opportunities that lie ahead of us. I look forward to making GlucoTrack a household name in diabetes care.”
Former Anthem President Jimmy Lee has joined the board of diabetes coaching platform Fit4D in a strategic advisory position. In the announcement, David Weingard, founder and CEO of Fit4D, said that the company is looking forward to leveraging Lee’s “extensive experience and expertise” in sales, profit and loss management, marketing and consumerism, among other areas.
“As a son and brother of family members with diabetes I have seen the complexities surrounding the management of diabetes,” Lee said in a statement. “Each person is unique, and I am excited to join the Fit4D team which has recognized these unique needs and built a platform of outreach, encouragement, empathy, and deep expertise to improve lives every day.”
Enterprise telehealth provider SnapMD has appointed Deric Frost as its new chief revenue officer. Frost, the cofounder of eVisit, has a history of leadership in the startup and SaaS healthcare landscape, and was called upon by SnapMD to support its scaling efforts.
“I’ve followed SnapMD for years and truly believe that their product, technology and customer-first approach set them aside from the other players in the space,” Frost said in a statement. “I am thrilled to join SnapMD to further drive the company as the leader in the platform-only telehealth space.”